Plasma Homocysteine and Risk of Coexisting Silent Brain Infarction in Alzheimer’s Disease

Abstract

SBIs commonly coexist with AD, and may be a unique vascular condition in which homocysteine plays an important role. Homocysteine-lowering therapy rather than antihypertensive medication might be an appropriate strategy to prevent stroke associated with AD.